Citigroup Inc Bausch Health Companies Inc. Put Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	BUY	$6.1 - $10.41 $610,000 - $1.04 Million	100,000 New	100,000 $697,000
Q4 2022 Feb 09, 2023	SELL	$6.09 - $7.93 $5.67 Million - $7.38 Million	-930,500 Reduced 92.53%	75,100 $471,000
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $1.97 Million - $3.96 Million	430,500 Added 74.86%	1,005,600 $6.98 Million
Q2 2022 Aug 10, 2022	SELL	$7.06 - $23.63 $2.26 Million - $7.56 Million	-319,900 Reduced 35.74%	575,100 $4.8 Million
Q4 2021 Feb 10, 2022	BUY	$23.0 - $29.01 $16 Million - $20.2 Million	695,000 Added 347.5%	895,000 $24.8 Million
Q3 2021 Nov 10, 2021	BUY	$25.04 - $30.06 $5.01 Million - $6.01 Million	200,000 New	200,000 $5.58 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.